What do systematic reviews say?

MSCs vs placebo or control

The review found no eligible studies for this question.

• Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic… 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Thrombopoietin mimetics vs placebo

The review found no eligible studies for this question.

• Thrombopoietin mimetics for patients with myelodysplastic syndromes 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Immunomodulatory drug maintenance therapy vs placebo/observation

The review found no eligible studies for this question.

• Maintenance therapy for chronic lymphocytic leukaemia 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Ruxolitinib vs placebo

Ruxolitinib may leads to higher health‐related quality of life Patients that achieved a reduction of… compared with placebo (low certainty).

• Janus kinase‐1 and Janus kinase‐2 inhibitors for treating myelofibrosis 2015 · Cochrane Headline outcomes only
  RR 8.82 [4.4, 17.69]
  1 study · 309 participants
  Low

Eculizumab vs placebo

• Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 87 participants
  Low